CorVel Corporation
CRVL
Rank in Stocks
#4003
CorVel Corporation delivers comprehensive solutions designed to assist... CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, CorVel enhances the oversight of entire healthcare episodes and their associated costs. Their service portfolio includes a wide array of network solutions, featuring automated medical fee auditing, management and reimbursement for preferred providers, retrospective utilization reviews, and detailed scrutiny of both facility and professional claims. Additionally, they offer pharmacy services, directed care programs, Medicare solutions, clearinghouse functionalities, independent medical examinations, and inpatient medical bill reviews. Beyond network services, CorVel provides a suite of patient management offerings, encompassing claims and case management, round-the-clock nurse triage, utilization management, vocational rehabilitation, and life care planning. The company also processes property and casualty claims specifically for self-insured clients. Established in 1987, CorVel maintains its corporate headquarters in Fort Worth, Texas.
Share Price
$81.14
Market Cap
$4.10B
Change (1 day)
1.79%
Change (1 year)
9.89%
Country
US
Trade CorVel Corporation (CRVL)
Category
Financial Services
P/E ratio for CorVel Corporation (CRVL)
P/E ratio as of October 2026 TTM: 35.73
According to CorVel Corporation latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 35.73. At the end of 2024 the company had a P/E ratio of 57.65.
P/E ratio history for CorVel Corporation from 2000 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 35.73 | -40.90% |
| 2025 | 60.46 | 4.88% |
| 2024 | 57.65 | 16.03% |
| 2023 | 49.69 | 10.34% |
| 2022 | 45.03 | 13.47% |
| 2021 | 39.68 | 88.21% |
| 2020 | 21.09 | -20.18% |
| 2019 | 26.41 | -0.92% |
| 2018 | 26.66 | -6.96% |
| 2017 | 28.65 | 3.21% |
| 2016 | 27.76 | 14.82% |
| 2015 | 24.18 | -20.83% |
| 2014 | 30.54 | 35.33% |
| 2013 | 22.57 | 22.79% |
| 2012 | 18.38 | -30.28% |
| 2011 | 26.36 | 57.30% |
| 2010 | 16.76 | 30.64% |
| 2009 | 12.83 | -29.24% |
| 2008 | 18.13 | -20.84% |
| 2007 | 22.90 | 4.56% |
| 2006 | 21.91 | 0.11% |
| 2005 | 21.88 | -8.49% |
| 2004 | 23.91 | 14.05% |
| 2003 | 20.96 | -6.96% |
| 2002 | 22.53 | 10.84% |
| 2001 | 20.33 | 16.40% |
| 2000 | 17.46 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 22.25 | -37.72% |
US
|
|
| 38.86 | 8.75% |
US
|
|
| 15.10 | -57.75% |
IE
|
|
| - | - |
GB
|
|
| - | - |
US
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.